Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Microscan Div. Baxter Healthcare Corp. — Predicate Candidate Screening
11 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
91 daysmedian FDA review time
93 days90th percentile
11clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K871229 | ANTIBODY ASSAY FOR DETECTION OF ADENOVIRUS IN CELL | Microscan Div. Baxter Healthcare Corp. | 1987-06-26 | 91 | 0 |
| K871234 | ANTIBODY ASSAY FOR DETECT. OF PARAINFLUENZA TYPE 1 | Microscan Div. Baxter Healthcare Corp. | 1987-06-26 | 91 | 0 |
| K871231 | ANTIBODY ASSAY FOR DETECTION OF INFLUENZA B | Microscan Div. Baxter Healthcare Corp. | 1987-06-26 | 91 | 0 |
| K871228 | ANTIBODY ASSAY FOR DETECT. OF PARAINFLUENZA TYPE 2 | Microscan Div. Baxter Healthcare Corp. | 1987-06-26 | 91 | 0 |
| K871230 | ANTIBODY ASSAY FOR DETEC. OF RESP. SYNCYTIAL VIRUS | Microscan Div. Baxter Healthcare Corp. | 1987-06-26 | 91 | 0 |
| K871233 | ANTIBODY ASSAY FOR DETECTION OF INFLUENZA A | Microscan Div. Baxter Healthcare Corp. | 1987-06-26 | 91 | 0 |
| K871232 | ANTIBODY ASSAY FOR DETECT. OF PARAINFLUENZA TYPE 3 | Microscan Div. Baxter Healthcare Corp. | 1987-06-26 | 91 | 0 |
| K870814 | HERPES SIMPLEX ANTIBODY TEST FOR DECT. OF HSV 1&2 | Microscan Div. Baxter Healthcare Corp. | 1987-06-04 | 93 | 0 |
| K870074 | GRAM NEGATIVE AND GRAM POSITIVE MIC/COMBO PANELS | Microscan Div. Baxter Healthcare Corp. | 1987-04-14 | 96 | 9 |
| K871033 | RABBIT KIDNEY CULTURE CELLS (FIRST PASS) | Microscan Div. Baxter Healthcare Corp. | 1987-03-31 | 15 | 0 |
| K870089 | IMMUNOSCAN(TM) DIRECT NEISSERIA MENINGITIDIS KIT | Microscan Div. Baxter Healthcare Corp. | 1987-03-17 | 67 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda